Evaluation of the efficacy and safety of lixisenatide add-on treatment to basal insulin therapy among T2DM patients with different body mass indices from GetGoal trials

BACKGROUND: Using patient data from the GetGoal-Duo1, -L, and L-Asia trials, the objectives of this study were to evaluate and compare the impact of lixisenatide once-daily add-on treatment to basal insulin therapy ±oral antidiabetic drugs (OADs) among type 2 diabetes (T2DM) patients subdivided into...

Descripción completa

Detalles Bibliográficos
Autores principales: Eto, Kazuhiro, Naito, Yusuke, Seino, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654794/
https://www.ncbi.nlm.nih.gov/pubmed/26594250
http://dx.doi.org/10.1186/s13098-015-0104-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654794/
https://www.ncbi.nlm.nih.gov/pubmed/26594250
http://dx.doi.org/10.1186/s13098-015-0104-6

Ejemplares similares